Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 37 clinical trials
Pilot Study of the eHealth Application (CAPABLE-IT)

The purpose of the CAPABLE study is to compare health-related quality of life in renal cell carcinoma patients who use or do not use a mobile-based application to monitor adverse events for cancer treatment at home. As secondary objectives, the study investigates the usability of the system and its generalizability …

  • 0 views
  • 08 Dec, 2023
Anabolic Effects of Intraoperative Feeding in Reconstruction Surgery

Perioperative fasting remains a common clinical practice in surgical patients to prevent the development of postoperative anesthesia- and surgical-related complications. Clinical observational studies indicated that the combination catabolic effects resulted from prolonged perioperative fasting and profound surgical stress are likely to induce extensive protein catabolism, muscle breakdown and impaired glycemic …

enteral nutrition
insulin sensitivity
tube feeding
cancer
fasting
  • 0 views
  • 16 Feb, 2024
  • 1 location
Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity

This study will investigate the effects of atezolizumab on select cancer types in people whose analysis of tumour DNA and RNA indicates they may be sensitive to atezolizumab. This study aims to determine if the information from the cancer genome analysis corresponds with the effects of atezolizumab on individuals and …

measurable disease
sarcoma
gastrointestinal cancer
bone metastases
international normalized ratio
  • 0 views
  • 16 Feb, 2024
  • 1 location
AcceleRET Lung Study of Pralsetinib for 1L RET Fusion-positive Metastatic NSCLC

This is an international, randomized, open-label, Phase 3 study designed to evaluate whether the potent and selective RET inhibitor, pralsetinib, improves outcome when compared to a platinum chemotherapy-based regimen chosen by the Investigator from a list of standard of care treatments, as measured primarily by progression free survival (PFS), for …

ret inhibitor
head and neck neoplasms
respiratory tract diseases
pembrolizumab
carcinoma
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Study of SGN-B6A in Advanced Solid Tumors

This trial will look at a drug called SGN-B6A to find out whether it is safe for people who have solid tumors. It will study SGN-B6A to find out what its side effects are. A side effect is anything the drug does besides treating cancer. It will also study whether …

measurable disease
small cell lung cancer
squamous cell carcinoma of head and neck
gastric cancer
ovarian ca
  • 0 views
  • 05 Aug, 2020
Pilot Study to Evaluate Photoacoustic Imaging in Head and Neck Cancer

In this study, PA imaging will be used to examine the physiological and physical changes in lymph node involvements of head and neck cancer during radiotherapy with or without chemotherapy. Our objective in this pilot study will be to evaluate if PA parameters change within the lymph node involvements during …

measurable disease
chemoradiation therapy
head and neck carcinoma
renal function test
carcinoma
  • 0 views
  • 16 Feb, 2024
  • 1 location
Skin Biophysical Measures for Assessing Head and Neck Cancer-Related External Lymphedema

Selected measurements in healthy persons of skin tissue dielectric constant as reference values for subsequent use to evaluate patients with head and neck lymphedema.

  • 0 views
  • 16 Feb, 2024
  • 1 location
Cetuximab Therapeutic Drug Monitoring in Squamous Cell Carcinoma Head and Neck Cancer Patients: Determination of the Predictive Value Exposure Levels Through a Single Arm Multicentric Study

Only about 30 percent of cancer patients have a clinical benefit upon cetuximab administration. Pilot studies in colorectal and head and neck cancer patients have suggested that cetuximab pharmacokinetics (PK), i.e. clearance values, could impact on clinical outcomes such as survival.

cetuximab
carboplatin
squamous cell carcinoma of head and neck
squamous cell carcinoma
carcinoma
  • 0 views
  • 16 Feb, 2024
  • 1 location
Establishment of Squamous Cell Organoids of the Head and Neck to Assess Their Response to Innovative Therapies

The emergence of tumor organoid cultures in recent years has made it possible to widen the repertoire of available preclinical tumor models and to bridge the gap between cell lines and tumors of xenografted patients in mice (PDXs).These organoids have the advantages of being able to be amplified fairly quickly …

mouth cancer
immunomodulator
squamous cell carcinoma of the oral cavity
squamous cell carcinoma
carcinoma
  • 0 views
  • 16 Feb, 2024
  • 1 location
Safety Validation of EndoSWIR Device

Head and neck cancer has an incidence of 600,000 cases per year worldwide (6th among cancers) and cause 380,000 death per year. Surgical resection is guided by the surgeon's inspection and palpation of the tumor.

  • 0 views
  • 16 Feb, 2024
  • 1 location